Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. William Gradishar

Breast Oncology · NU

View

Dr. Jame Abraham

Breast Oncology · Cleveland Clinic

View

Dr. Azka Ali

Breast Oncology · Cleveland Clinic Lerner

View

Dr. Amy Comander

Breast Oncology · PHS

View

Dr. Paolo Tarantino

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Anastasia Martynova

Breast Oncology · USC

View

Dr. Rani Bansal

Breast Oncology · Duke

View

Dr. Gilbert Bader

Breast Oncology · OSUMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    SKDr. Sheheryar Kabraji

    Dr. Sheheryar Kabraji

    Hematology & Oncology · Breast Oncology
    Roswell Park Comprehensive Cancer Center
    sheheryar

    Research

    Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 Inhibitors

    2026

    Via JCO Precision Oncology

    Research

    BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials

    2026

    Via Journal of the National Comprehensive Cancer Network

    Research

    The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond

    2026

    Via Nature Reviews. Drug Discovery

    Research

    Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates

    2026

    Via Journal of the National Cancer Institute

    Research

    Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis

    2025

    Via ESMO Open

    Research

    Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor-positive breast cancer

    2025

    Via JCI Insight

    Research

    Area deprivation index and breast cancer outcomes among patients in Western New York

    2025

    Via Breast Cancer Research and Treatment

    Research

    RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

    2024

    Via Clinical Cancer Research

    Research

    Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer

    2024

    Via NPJ Breast Cancer

    Research

    Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy

    2024

    Via Cancer Treatment Reviews

    Research

    Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases

    2023

    Via Clinical Cancer Research

    Research

    PI3Kβ controls immune evasion in PTEN-deficient breast tumours

    2023

    Via Nature

    Research

    Keeping It in the Family: HER3 as a Target in Brain Metastases

    2023

    Via Clinical Cancer Research

    Research

    Temporal and spatial topography of cell proliferation in cancer

    2022

    Via Nature Cell Biology

    Research

    p16-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases

    2022

    Via Nature Communications